{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:25:31Z","timestamp":1791919531892,"version":"4.3.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T00:00:00Z","timestamp":1567468800000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R01GM79383"],"award-info":[{"award-number":["R01GM79383"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["P30 DA035778-01A1"],"award-info":[{"award-number":["P30 DA035778-01A1"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["DOD W81XWH-16-1-0490:412288"],"award-info":[{"award-number":["DOD W81XWH-16-1-0490:412288"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"crossref","award":["ULITR001857"],"award-info":[{"award-number":["ULITR001857"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs R D"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s40268-019-00282-3","type":"journal-article","created":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T18:49:05Z","timestamp":1567536545000},"page":"297-305","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Prediction of Drug\u2013Drug Interactions Between Opioids and Overdosed Benzodiazepines Using Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation"],"prefix":"10.1007","volume":"19","author":[{"given":"Beihong","family":"Ji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xibing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viet Hoang","family":"Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Qun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9607-8229","authenticated-orcid":false,"given":"Junmei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,3]]},"reference":[{"key":"282_CR1","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ssmph.2017.01.009","volume":"3","author":"CJ Ruhm","year":"2017","unstructured":"Ruhm CJ. Drug involvement in fatal overdoses. SSM Popul Health. 2017;3:219\u201326. \n                    https:\/\/doi.org\/10.1016\/j.ssmph.2017.01.009\n                    \n                  .","journal-title":"SSM Popul Health."},{"issue":"2","key":"282_CR2","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/0885-3924(93)90101-Z","volume":"8","author":"R P\u00f6yhi\u00e4","year":"1993","unstructured":"P\u00f6yhi\u00e4 R, Vainio A, Kalso E. A review of oxycodone\u2019s clinical pharmacokinetics and pharmacodynamics. J Pain Symptom Manag. 1993;8(2):63\u20137. \n                    https:\/\/doi.org\/10.1016\/0885-3924(93)90101-Z\n                    \n                  .","journal-title":"J Pain Symptom Manag"},{"issue":"1\u20132","key":"282_CR3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.drugalcdep.2012.07.004","volume":"125","author":"JD Jones","year":"2012","unstructured":"Jones JD, Mogali S, Comer SD. Polydrug abuse: a review of opioid and benzodiazepine combination use. Drug Alcohol Depend. 2012;125(1\u20132):8\u201318.","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"282_CR4","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1056\/NEJMsa1406143","volume":"372","author":"RC Dart","year":"2015","unstructured":"Dart RC, Surratt HL, Cicero TJ, Parrino MW, Severtson SG, Bucher-Bartelson B, et al. Trends in opioid analgesic abuse and mortality in the United States. N Engl J Med. 2015;372(3):241\u20138. \n                    https:\/\/doi.org\/10.1056\/NEJMsa1406143\n                    \n                  .","journal-title":"N Engl J Med"},{"key":"282_CR5","doi-asserted-by":"crossref","unstructured":"Olkkola K, Ahonen J. Midazolam and other benzodiazepines. Modern anesthetics. Springer; 2008. p. 335\u201360.","DOI":"10.1007\/978-3-540-74806-9_16"},{"issue":"1","key":"282_CR6","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.drugalcdep.2012.07.004","volume":"125","author":"JD Jones","year":"2012","unstructured":"Jones JD, Mogali S, Comer SD. Polydrug abuse: a review of opioid and benzodiazepine combination use. Drug Alcohol Depend. 2012;125(1):8\u201318. \n                    https:\/\/doi.org\/10.1016\/j.drugalcdep.2012.07.004\n                    \n                  .","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"282_CR7","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1177\/0897190013515001","volume":"27","author":"M Jann","year":"2014","unstructured":"Jann M, Kennedy WK, Lopez G. Benzodiazepines: a major component in unintentional prescription drug overdoses with opioid analgesics. J Pharm Pract. 2014;27(1):5\u201316.","journal-title":"J Pharm Pract."},{"issue":"1","key":"282_CR8","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.drugalcdep.2005.01.004","volume":"79","author":"S Nielsen","year":"2005","unstructured":"Nielsen S, Taylor DA. The effect of buprenorphine and benzodiazepines on respiration in the rat. Drug Alcohol Depend. 2005;79(1):95\u2013101.","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"282_CR9","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1097\/01.jcp.0000219050.33008.61","volume":"26","author":"N Lintzeris","year":"2006","unstructured":"Lintzeris N, Mitchell TB, Bond A, Nestor L, Strang J. Interactions on mixing diazepam with methadone or buprenorphine in maintenance patients. J Clin Psychopharmacol. 2006;26(3):274\u201383.","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"282_CR10","doi-asserted-by":"publisher","first-page":"e0150214","DOI":"10.1371\/journal.pone.0150214","volume":"11","author":"FJ Overdyk","year":"2016","unstructured":"Overdyk FJ, Dowling O, Marino J, Qiu J, Chien H-L, Erslon M, et al. Association of opioids and sedatives with increased risk of in-hospital cardiopulmonary arrest from an administrative database. PLoS One. 2016;11(2):e0150214.","journal-title":"PLoS One"},{"issue":"1","key":"282_CR11","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1521-0391.2009.00007.x","volume":"19","author":"N Lintzeris","year":"2010","unstructured":"Lintzeris N, Nielsen S. Benzodiazepines, methadone and buprenorphine: interactions and clinical management. Am J Addict. 2010;19(1):59\u201372. \n                    https:\/\/doi.org\/10.1111\/j.1521-0391.2009.00007.x\n                    \n                  .","journal-title":"Am J Addict"},{"issue":"1","key":"282_CR12","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1521-0391.2009.00005.x","volume":"19","author":"EF McCance-Katz","year":"2010","unstructured":"McCance-Katz EF, Sullivan LE, Nallani S. Drug interactions of clinical importance among the opioids, methadone and buprenorphine, and other frequently prescribed medications: a review. Am J Addict. 2010;19(1):4\u201316. \n                    https:\/\/doi.org\/10.1111\/j.1521-0391.2009.00005.x\n                    \n                  .","journal-title":"Am J Addict"},{"key":"282_CR13","first-page":"S276","volume":"17","author":"BR Overholser","year":"2011","unstructured":"Overholser BR, Foster DR. Opioid pharmacokinetic drug-drug interactions. Am J Manag Care. 2011;17:S276\u201387.","journal-title":"Am J Manag Care"},{"issue":"5","key":"282_CR14","first-page":"458","volume":"2","author":"TC Spaulding","year":"1974","unstructured":"Spaulding TC, Minium L, Kotake AN, Takemori AE. The effect of diazepam on the metabolism of methadone by the liver of methadone dependent rats. Drug Metab Dispos. 1974;2(5):458\u201363.","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"282_CR15","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/sj.clpt.6100095","volume":"81","author":"AA Somogyi","year":"2007","unstructured":"Somogyi AA, Barratt DT, Coller JK. Pharmacogenetics of opioids. Clin Pharmacol Ther. 2007;81(3):429\u201344.","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"282_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/00498250903337392","volume":"40","author":"Y Nishiya","year":"2010","unstructured":"Nishiya Y, Nakamura K, Okudaira N, Abe K, Kobayashi N, Okazaki O. Effects of organic solvents on the time-dependent inhibition of CYP3A4 by diazepam. Xenobiotica. 2010;40(1):1\u20138. \n                    https:\/\/doi.org\/10.3109\/00498250903337392\n                    \n                  .","journal-title":"Xenobiotica"},{"issue":"1","key":"282_CR17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0300-483X(96)03549-4","volume":"117","author":"C Iribarne","year":"1997","unstructured":"Iribarne C, Dr\u00e9ano Y, Bardou LG, M\u00e9nez JF, Berthou F. Interaction of methadone with substrates of human hepatic cytochrome P450 3A4. Toxicology. 1997;117(1):13\u201323. \n                    https:\/\/doi.org\/10.1016\/S0300-483X(96)03549-4\n                    \n                  .","journal-title":"Toxicology"},{"issue":"12","key":"282_CR18","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s00228-004-0856-7","volume":"60","author":"Y Chang","year":"2005","unstructured":"Chang Y, Moody DE. Effect of benzodiazepines on the metabolism of buprenorphine in human liver microsomes. Eur J Clin Pharmacol. 2005;60(12):875\u201381. \n                    https:\/\/doi.org\/10.1007\/s00228-004-0856-7\n                    \n                  .","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"282_CR19","first-page":"750","volume":"25","author":"RW Nims","year":"1997","unstructured":"Nims RW, Prough RA, Jones CR, Stockus DL, Dragnev KH, Thomas PE, et al. In vivo induction and in vitro inhibition of hepatic cytochrome P450 activity by the benzodiazepine anticonvulsants clonazepam and diazepam. Drug Metab Dispos. 1997;25(6):750\u20136.","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"282_CR20","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1520\/JFS2002323","volume":"48","author":"DL Burrows","year":"2003","unstructured":"Burrows DL, Hagardorn AN, Harlan GC, Wallen ED, Ferslew KE. A fatal drug interaction between oxycodone and clonazepam. J Forensic Sci. 2003;48(3):683\u20136.","journal-title":"J Forensic Sci"},{"issue":"7","key":"282_CR21","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/S0025-6196(11)60750-7","volume":"84","author":"HS Smith","year":"2009","unstructured":"Smith HS. Opioid metabolism. Mayo Clin Proc. 2009;84(7):613\u201324. \n                    https:\/\/doi.org\/10.1016\/S0025-6196(11)60750-7\n                    \n                  .","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"282_CR22","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1124\/dmd.32.4.447","volume":"32","author":"B Lalovic","year":"2004","unstructured":"Lalovic B, Phillips B, Risler LL, Howald W, Shen DD. Quantitative contribution of CYP2D6 and CYP3A to oxycodone metabolism in human liver and intestinal microsomes. Drug Metab Dispos. 2004;32(4):447.","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"282_CR23","first-page":"48","volume":"52","author":"EA Nunamaker","year":"2013","unstructured":"Nunamaker EA, Halliday LC, Moody DE, Fang WB, Lindeblad M, Fortman JD. Pharmacokinetics of 2 formulations of buprenorphine in Macaques (Macaca mulatta and Macaca fascicularis). J Am Assoc Lab Anim Sci. 2013;52(1):48\u201356.","journal-title":"J Am Assoc Lab Anim Sci"},{"issue":"3","key":"282_CR24","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1742-7843.2009.00432.x","volume":"105","author":"DE Moody","year":"2009","unstructured":"Moody DE, Chang Y, Huang W, McCance-Katz EF. The in vivo response of novel buprenorphine metabolites, M1 and M3, to antiretroviral inducers and inhibitors of buprenorphine metabolism. Basic Clin Pharmacol Toxicol. 2009;105(3):211\u20135. \n                    https:\/\/doi.org\/10.1111\/j.1742-7843.2009.00432.x\n                    \n                  .","journal-title":"Basic Clin Pharmacol Toxicol."},{"key":"282_CR25","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jpba.2016.09.024","volume":"144","author":"S Romand","year":"2017","unstructured":"Romand S, Spaggiari D, Marsousi N, Samer C, Desmeules J, Daali Y, et al. Characterization of oxycodone in vitro metabolism by human cytochromes P450 and UDP-glucuronosyltransferases. J Pharm Biomed Anal. 2017;144:129\u201337. \n                    https:\/\/doi.org\/10.1016\/j.jpba.2016.09.024\n                    \n                  .","journal-title":"J Pharm Biomed Anal"},{"issue":"11","key":"282_CR26","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1111\/bcp.13368","volume":"83","author":"HV Kalluri","year":"2017","unstructured":"Kalluri HV, Zhang H, Caritis SN, Venkataramanan R. A physiologically based pharmacokinetic modelling approach to predict buprenorphine pharmacokinetics following intravenous and sublingual administration. Br J Clin Pharmacol. 2017;83(11):2458\u201373. \n                    https:\/\/doi.org\/10.1111\/bcp.13368\n                    \n                  .","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"282_CR27","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/bdd.261","volume":"22","author":"N Hirota","year":"2001","unstructured":"Hirota N, Ito K, Iwatsubo T, Green CE, Tyson CA, Shimada N, et al. In vitro\/in vivo scaling of alprazolam metabolism by CYP3A4 and CYP3A5 in humans. Biopharm Drug Dispos. 2001;22(2):53\u201371. \n                    https:\/\/doi.org\/10.1002\/bdd.261\n                    \n                  .","journal-title":"Biopharm Drug Dispos"},{"issue":"7","key":"282_CR28","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1124\/dmd.31.7.938","volume":"31","author":"KC Patki","year":"2003","unstructured":"Patki KC, von Moltke LL, Greenblatt DJ. In vitro metabolism of midazolam, triazolam, nifedipine, and testosterone by human liver microsomes and recombinant cytochromes p450: role of cyp3a4 and cyp3a5. Drug Metab Dispos. 2003;31(7):938\u201344. \n                    https:\/\/doi.org\/10.1124\/dmd.31.7.938\n                    \n                  .","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"282_CR29","first-page":"133","volume":"25","author":"F Jung","year":"1997","unstructured":"Jung F, Richardson TH, Raucy JL, Johnson EF. Diazepam metabolism by DNA-expressed human 2C P450. Drug Metab Dispos. 1997;25(2):133.","journal-title":"Drug Metab Dispos"},{"key":"282_CR30","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s40262-013-0097-y","volume":"53","author":"M Jamei","year":"2013","unstructured":"Jamei M, Bajot F, Neuhoff S, Barter Z, Yang J, Rostami-Hodjegan A, et al. A mechanistic framework for in vitro\u2013in vivo extrapolation of liver membrane transporters: prediction of drug\u2013drug interaction between rosuvastatin and cyclosporine. Clin Pharmacokinet. 2013;53:73\u201387.","journal-title":"Clin Pharmacokinet."},{"key":"282_CR31","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.ejps.2013.09.008","volume":"57","author":"ES Kostewicz","year":"2014","unstructured":"Kostewicz ES, Aarons L, Bergstrand M, Bolger MB, Galetin A, Hatley O, et al. PBPK models for the prediction of in vivo performance of oral dosage forms. Eur J Pharm Sci. 2014;57:300\u201321. \n                    https:\/\/doi.org\/10.1016\/j.ejps.2013.09.008\n                    \n                  .","journal-title":"Eur J Pharm Sci"},{"key":"282_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2018.12.004","volume":"196","author":"Z Dai","year":"2019","unstructured":"Dai Z, Abate MA, Smith GS, Kraner JC, Mock AR. Fentanyl and fentanyl-analog involvement in drug-related deaths. Drug Alcohol Depend. 2019;196:1\u20138. \n                    https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.12.004\n                    \n                  .","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"282_CR33","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1093\/jat\/20.6.369","volume":"20","author":"JJ Kuhlman Jr","year":"1996","unstructured":"Kuhlman JJ Jr, Lalani S, Magluilo J Jr, Levine B, Darwin WD, Johnson RE, et al. Human pharmacokinetics of intravenous, sublingual, and buccal buprenorphine. J Anal Toxicol. 1996;20(6):369\u201378. \n                    https:\/\/doi.org\/10.1093\/jat\/20.6.369\n                    \n                  .","journal-title":"J Anal Toxicol"},{"issue":"3","key":"282_CR34","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.taap.2013.05.024","volume":"273","author":"H Shankaran","year":"2013","unstructured":"Shankaran H, Adeshina F, Teeguarden JG. Physiologically-based pharmacokinetic model for fentanyl in support of the development of Provisional Advisory Levels. Toxicol Appl Pharmacol. 2013;273(3):464\u201376. \n                    https:\/\/doi.org\/10.1016\/j.taap.2013.05.024\n                    \n                  .","journal-title":"Toxicol Appl Pharmacol"},{"issue":"5","key":"282_CR35","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1124\/dmd.31.5.519","volume":"31","author":"JL Donovan","year":"2003","unstructured":"Donovan JL, DeVane CL, Chavin KD, Taylor RM, Markowitz JS. Siberian ginseng (Eleutheroccus senticosus) effects on CYP2D6 and CYP3A4 activity in normal volunteers. Drug Metab Dispos. 2003;31(5):519\u201322.","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"282_CR36","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/clpt.1992.123","volume":"52","author":"H Friedman","year":"1992","unstructured":"Friedman H, Greenblatt DJ, Peters GR, Metzler CM, Charlton MD, Harmatz JS, et al. Pharmacokinetics and pharmacodynamics of oral diazepam: effect of dose, plasma concentration, and time. Clin Pharmacol Ther. 1992;52(2):139\u201350.","journal-title":"Clin Pharmacol Ther"},{"key":"282_CR37","doi-asserted-by":"publisher","first-page":"730734","DOI":"10.1155\/2013\/730734","volume":"2013","author":"F Qiu","year":"2013","unstructured":"Qiu F, Jiang J, Ma Y, Wang G, Gao C, Zhang X, et al. Opposite effects of single-dose and multidose administration of the ethanol extract of danshen on CYP3A in healthy volunteers. Evid Based Complement Alternat Med eCAM. 2013;2013:730734. \n                    https:\/\/doi.org\/10.1155\/2013\/730734\n                    \n                  .","journal-title":"Evid Based Complement Alternat Med eCAM."},{"issue":"24","key":"282_CR38","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJM199106133242403","volume":"324","author":"DJ Greenblatt","year":"1991","unstructured":"Greenblatt DJ, Harmatz JS, Shapiro L, Engelhardt N, Gouthro TA, Shader RI. Sensitivity to triazolam in the elderly. N Engl J Med. 1991;324(24):1691\u20138. \n                    https:\/\/doi.org\/10.1056\/NEJM199106133242403\n                    \n                  .","journal-title":"N Engl J Med"}],"container-title":["Drugs in R&D"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40268-019-00282-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40268-019-00282-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40268-019-00282-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T23:18:00Z","timestamp":1599002280000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40268-019-00282-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["282"],"URL":"https:\/\/doi.org\/10.1007\/s40268-019-00282-3","relation":{},"ISSN":["1174-5886","1179-6901"],"issn-type":[{"value":"1174-5886","type":"print"},{"value":"1179-6901","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"3 September 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"No sources of funding were used to conduct this study or prepare this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Beihong Ji, Shuhan Liu, Ying Xue, Xibing He, Viet Hoang Man, Xiang-Qun Xie and Junmei Wang have no conflicts of interest that are directly relevant to the content of this review\/study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}